ApoB Optimal Range: What Your Number Means and How to Lower It

An optimal ApoB is below 80 mg/dL (0.80 g/L), and if you are optimizing aggressively for long-term cardiovascular health the target worth aiming for is under 60–65 mg/dL (0.60–0.65 g/L) — the goal the 2019 ESC/EAS dyslipidaemia guidelines set for their highest-risk patients. 80–99 mg/dL is borderline, 100–119 mg/dL is high, and 120 mg/dL (1.20 g/L) or above is very high. ApoB counts the actual number of cholesterol-carrying particles in your blood — exactly one ApoB molecule per particle — which is why it predicts cardiovascular risk better than LDL cholesterol and why it is the single most informative lipid number a self-tracker can follow.

Unit conversion is simple: divide mg/dL by 100 to get g/L. These bands synthesize the ESC/EAS treatment goals (below 65, 80 and 100 mg/dL depending on risk category) with the 2018 AHA/ACC cholesterol guideline, which treats ApoB at or above 130 mg/dL as roughly equivalent to an LDL-C of 160 mg/dL or more.

My ApoB is 110 — how bad is it?

An ApoB of 110 mg/dL (1.10 g/L) sits squarely in the high band. It is above the 100 mg/dL goal the ESC/EAS guidelines set even for people at only moderate risk, and in a concordant lipid profile it corresponds roughly to an LDL-C in the 130s. It is not an emergency, and one number is not a verdict — but it is a clear signal to act rather than shrug.

The reason is cumulative exposure. The EAS consensus analysis by Ference and colleagues showed that atherosclerosis risk scales with both the level of atherogenic lipoproteins and the number of years you carry that level — a log-linear, dose- and time-dependent relationship. An ApoB of 110 at age 35 buys far more plaque over the next three decades than the same number first seen at 70. That is also the good news: lowering ApoB earlier pays compound interest.

Practical framing for a 110: first, confirm it — repeat the test in 4–8 weeks at the same lab before drawing conclusions. Second, read it in context: blood pressure, smoking, family history, Lp(a) if you have ever measured it, and metabolic health markers such as fasting insulin, because insulin resistance is exactly the state where ApoB runs higher than your LDL-C suggests. Third, intervene and retest — the levers below are quantified.

Why is ApoB better than LDL-C?

LDL-C measures the mass of cholesterol packed inside LDL particles. ApoB counts the particles themselves: every LDL, VLDL, IDL and Lp(a) particle carries exactly one ApoB molecule, and about 90 percent of them are LDL. Particles — not cholesterol mass — are what cross the artery wall and get retained, so particle number is the more direct measure of atherogenic pressure. That is the core argument of the Sniderman 2019 narrative review in JAMA Cardiology, and it was the position of the AACC working group on best practices back in 2009.

The two numbers usually move together, but they diverge — discordance — in a substantial minority of adults, with estimates commonly in the range of one in five depending on the cutoffs used. If your particles are small and cholesterol-poor (typical of insulin resistance and high triglycerides), your LDL-C can look acceptable while your particle count is high. You would be under-treated by an LDL-C-only panel. The reverse pattern — large particles, flattering ApoB, alarming LDL-C — also exists.

When both are measured, ApoB wins. In a UK Biobank analysis of several hundred thousand adults, Marston and colleagues found that once ApoB was known, neither LDL-C nor triglycerides added meaningful information for predicting myocardial infarction. Verdict for trackers: if you can only follow one lipid number, follow ApoB; keep LDL-C as the supporting cast. Log each ApoB result in BioTrakk by chat and it will chart the trend next to your LDL-C, so discordance shows up instead of hiding in a PDF.

How can you lower ApoB naturally — and by how much?

Honest numbers first: realistic lifestyle change moves ApoB by roughly 5–20 percent for most people. Meaningful, sometimes decisive if you start at 90 — rarely enough on its own if you start at 140. The levers, in order of evidence:

Swap saturated fat for unsaturated fat

The Mensink meta-analysis of 60 controlled feeding trials shows that replacing saturated fat with polyunsaturated or monounsaturated fat lowers ApoB and LDL-C in parallel; swapping about 5 percent of daily calories (roughly the difference between butter and olive oil as your main fat) lowers LDL-C on the order of 10 mg/dL (0.25 mmol/L). This is the largest single dietary lever, and it works without cutting total fat.

Viscous fiber, especially psyllium

A meta-analysis of 28 randomized trials found that a median dose of about 10 g of psyllium per day lowered ApoB by 0.05 g/L (5 mg/dL) and LDL-C by 0.33 mmol/L (about 13 mg/dL). Oats, legumes and other beta-glucan sources act through the same bile-acid mechanism. Cheap, boring, effective.

Weight loss if you carry excess visceral fat

In men with metabolic syndrome, a Mediterranean-style diet followed by roughly 10 percent weight loss reduced the LDL-ApoB100 particle pool by about 14 percent, mainly by speeding particle clearance. If your waist and fasting insulin are elevated, weight loss is likely your highest-yield lever; if you are already lean, expect little from this one.

Aerobic exercise — modest, be realistic

A 2023 multivariate meta-analysis of randomized trials found aerobic training lowers ApoB by only about 2 mg/dL on average. Exercise earns its place through triglycerides, insulin sensitivity, blood pressure and fitness — not as an ApoB drug. Anyone promising big ApoB drops from cardio alone is overselling.

Because responses vary widely between individuals, the only way to know your numbers is to test the intervention on yourself: run an 8–12 week n-of-1 experiment — baseline draw, one change at a time, retest — and BioTrakk will tell you honestly whether your result beats measurement noise.

When is lifestyle not enough?

Sometimes the honest answer is: your liver did not read your meal plan. ApoB is strongly genetically influenced — heterozygous familial hypercholesterolaemia alone affects roughly 1 in 250 people, and polygenic high ApoB plus elevated Lp(a) are far more common than that. If you have executed a serious 3–6 month lifestyle block — fat-quality swap, 10 g of daily viscous fiber, weight loss if applicable — and your ApoB still sits above 100 mg/dL, or above 80 with other risk factors, the next conversation belongs with a physician, not with another supplement stack.

What that conversation typically covers: your overall risk (family history, Lp(a), blood pressure, possibly a coronary calcium scan) and whether medication makes sense. For scale, guideline-classified high-intensity statins lower LDL-C by around 50 percent, and ezetimibe adds roughly a further 15–20 percent; ApoB falls slightly less in percentage terms than LDL-C. Whether any of that applies to you is a medical decision — BioTrakk is not a medical device and does not give medical advice, but arriving with a clean, dated trend of your ApoB, diet changes and weight makes that appointment dramatically more productive. Choosing pharmacology when lifestyle maxes out is not a failure; carrying an ApoB of 130 for a decade out of pride is.

How often should you retest ApoB?

While actively intervening, retest every 3–6 months — lipoprotein metabolism responds to a diet change within weeks, so a 12-week interval cleanly captures the effect. In maintenance mode, once a year is enough. Three practical rules: use the same laboratory when possible; do not over-interpret single readings, since ApoB fluctuates between draws and a trend of two or three measurements beats any one number; and note that fasting is not required — European guidelines accept non-fasting samples, and the ApoB assay itself is standardized and inexpensive, often a small add-on to a routine panel.

Since you are drawing blood anyway, it is efficient to batch ApoB with the rest of a self-tracker panel — ferritin, fasting insulin, and your other quarterly markers — and log them all in one place so each intervention window has a clean before and after.